Dr. Hilden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
13123 E 16th St
Box B115
Aurora, CO 80045Phone+1 720-777-3492Fax+1 720-777-7279- Is this information wrong?
Education & Training
- University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1991 - 1994
- University of MinnesotaResidency, Pediatrics, 1988 - 1991
- University of Minnesota Medical SchoolClass of 1988
Certifications & Licensure
- CO State Medical License 2011 - 2019
- IN State Medical License 2007 - 2013
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Indianapolis Monthly Castle Connolly, 2007, 2009-2010
- Join now to see all
Clinical Trials
- Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2008 Jan 15
Publications & Presentations
PubMed
- 10 citationsOutstanding outcomes in infants with-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial.Erin M Guest, John A Kairalla, Joanne M Hilden, ZoAnn E Dreyer, Andrew J Carroll, Nyla A Heerema, Cindy Y Wang, Meenakshi Devidas, Lia Gore, Wanda L Salzer, Naomi J Wi...> ;Haematologica. 2022 May 1
- 4 citationsPediatric mediastinal mass algorithm: A quality improvement initiative to reduce time from presentation to biopsy.Jamie M Fleming, Savannah Ross, Lindsey Hoffman, Rebecca L Coughlin, Timothy M. Crombleholme, David A. Mong, Joanne M. Hilden, Kelly W. Maloney, Gee Mei Tan> ;Paediatric Anaesthesia. 2021 Aug 1
- 2 citationsCorrection to: FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial ...Patrick A. Brown, John A. Kairalla, Joanne M. Hilden, Zo Ann E. Dreyer, Andrew J. Carroll, Nyla A. Heerema, Cindy Wang, Meenakshi Devidas, Lia Gore, Wanda L. Salzer, N...> ;Leukemia. 2021 May 1
- Join now to see all
Journal Articles
- Targeting EIF4E Signaling with Ribavirin in Infant Acute Lymphoblastic LeukemiaNyla A Heerema, James W Davenport, Carolyn A Felix, Andrew J Carroll, ZoAnn E Dreyer, Alix E Seif, David T Teachey, Joanne M Hilden, Sarah K Tasian, Cheryl L Willman, ..., Nature
Press Mentions
- COVID-19 ‘Vaccine Hunters’ Snagging Doses for Older OhioansMarch 15th, 2021
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: